サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1415717

スマートライフサイエンス製造の世界市場レポート 2024年

Smart Life Sciences Manufacturing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
スマートライフサイエンス製造の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

スマートライフサイエンス製造の市場規模は近年急速に拡大しています。2023年の218億3,000万米ドルから2024年には250億7,000万米ドルに、CAGR14.8％で拡大します。実績期間の成長は、サプライチェーンの最適化、遠隔モニタリングの増加、精密医療の需要、ヘルスケア支出の増加に起因しています。

スマートライフサイエンス製造市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR14.9％で437億5,000万米ドルに成長します。予測期間の成長は、先端材料の開発、フレキシブルでウェアラブルなエレクトロニクスの需要、エネルギー効率、iotデバイスの需要増に起因すると考えられます。予測期間の主な動向には、人工知能（AI）と機械学習（ML）、RFIDとセンサー技術、太陽光発電アプリケーション、ディスプレイ技術などがあります。

自動化の導入が加速しており、当面のスマートライフサイエンス製造市場の成長を牽引するものと見られます。自動化とは、反復的なプロセスを引き継ぎ、手作業の介入を抑制するためのソフトウェアやシステムの構築を意味し、手作業に代わる反復的なプロセスを確立するための命令の活用が含まれます。スマートライフサイエンス製造では、オートメーションは、医薬品、バイオテクノロジー製品、医療機器、関連商品の生産における効率、品質、安全性を向上させるという極めて重要な役割を担っています。例えば、2022年2月、ドイツを拠点とする非営利団体である国際ロボット連盟のデータによると、世界中の産業界ですでに300万台の産業用ロボットが使用されており、2021年から10％の急増を記録しています。世界の大流行にもかかわらず、新型ロボットの販売台数は0.5％増で、2020年の世界販売台数は38万4,000台だった。さらに、2021年には世界のロボット設置台数の大幅な回復が予想され、13％増の43万5,000台に急増すると予測されています。このように、産業オートメーションの盛り上がりがスマートライフサイエンス製造市場の拡大を後押ししています。

個別化医療への需要の高まりは、スマートライフサイエンス製造市場成長の原動力となります。個別化医療とは、医療上の意思決定、実践、介入、治療を個々の患者に合わせてカスタマイズする医療やヘルスケアへのアプローチを意味します。個別化医療に対するニーズの高まりにより、ライフサイエンス分野ではスマート製造技術や手順の導入が迫られており、効率的で正確、かつ適応性の高いカスタマイズされた医薬品や治療法の製造が可能になり、治療成績が向上しています。例えば、2022年10月現在、米国を拠点とする健康専門の報道機関STATの報告によると、75,000を超える遺伝子検査製品と300を超える個別化医薬品の存在が示されています。さらに、米国の擁護団体である個別化医療連合（Personalized Medicine Coalition）のデータによると、2023年、FDAは新薬の34%に個別化医療を承認しました。過去8年間、個別化医療は新薬の25%以上に承認されており、一貫した傾向を示しています。したがって、個別化医療に対する需要の急増がスマートライフサイエンス製造市場の拡大を後押ししています。

2023年のスマートライフサイエンス製造市場で最大の地域は北米でした。アジア太平洋は予測期間中に最も急成長する地域と予想されます。スマートライフサイエンス製造レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のスマートライフサイエンス製造市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ソリューション
  • サービス
  • 世界のスマートライフサイエンス製造市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 拡張現実と仮想現実システム
  • モノのインターネット（IoT）
  • 人工知能
  • サイバーセキュリティ
  • ビッグデータ
  • その他の技術
  • 世界のスマートライフサイエンス製造市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬
  • バイオ医薬品
  • 医療機器

第7章 地域および国の分析

  • 世界のスマートライフサイエンス製造市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のスマートライフサイエンス製造市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • スマートライフサイエンス製造市場の競合情勢
  • スマートライフサイエンス製造市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson
    • Siemens AG
    • General Electric Co.
    • F. Hoffmann-La Roche AG

第31章 その他の主要および革新的な企業

  • International Business Machines Corporation
  • AbbVie Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Sophos Group plc
  • Bristol Myers Squibb
  • Thermo Fisher Scientific Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • AstraZeneca plc
  • Honeywell International Inc.
  • ABB Ltd.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12316

“Smart Life Sciences Manufacturing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart life sciences manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart life sciences manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The smart life sciences manufacturing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Component: Solution; Services
  • 2) By Technology: Augmented Reality And Virtual Reality Systems; Internet of Things (IoT); Artificial Intelligence; Cybersecurity; Big Data; Other Technologies
  • 3) By Application: Pharma; Bio-Pharma; Medical Device
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Siemens AG; General Electric Co.; F. Hoffmann-La Roche AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Smart life sciences manufacturing employs technology-driven strategies to oversee the production process within the life sciences industry, utilizing Internet-connected equipment. Its purpose is to identify opportunities for automation and enhance industrial performance through data analytics.

The main components of smart life sciences manufacturing are solutions and services. Solutions denote distinct and essential components within a larger system, incorporating various technologies like augmented reality and virtual reality systems, the Internet of Things (IoT), artificial intelligence, cybersecurity, big data, among others. These technologies find applications in pharmaceuticals, biopharmaceuticals, and medical devices.

The smart life sciences manufacturing market research report is one of a series of new reports from The Business Research Company that provides smart life sciences manufacturing market statistics, including smart life sciences manufacturing industry global market size, regional shares, competitors with a smart life sciences manufacturing market share, detailed smart life sciences manufacturing market segments, market trends and opportunities and any further data you may need to thrive in the smart life sciences manufacturing industry. This smart life sciences manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart life sciences manufacturing market size has grown rapidly in recent years. It will grow from $21.83 billion in 2023 to $25.07 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to supply chain optimization, increasing remote monitoring, demand for precision medicine, increasing healthcare expenditure.

The smart life sciences manufacturing market size is expected to see rapid growth in the next few years. It will grow to $43.75 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to advanced materials development, demand for flexible and wearable electronics, energy efficiency, increasing demand for iot devices. Major trends in the forecast period include artificial intelligence (AI) and machine learning (ML), RFID and sensor technologies, photovoltaic applications, display technologies.

The escalating adoption of automation is poised to steer the growth of the smart life sciences manufacturing market in the foreseeable future. Automation entails the creation of software and systems to take over repetitive processes and curtail manual intervention, involving the utilization of instructions for establishing a recurrent process that supplants manual labor. Within smart life sciences manufacturing, automation assumes a pivotal role, enhancing efficiency, quality, and safety in the production of pharmaceuticals, biotechnology products, medical devices, and related commodities. For instance, in February 2022, data from the International Federation of Robotics, a Germany-based non-profit organization, indicated that industries across the globe already employ 3 million industrial robots, marking a 10% surge from 2021. Despite the global pandemic, the sales of new robots saw a 0.5% rise, with a global sale of 384,000 units in 2020. Moreover, a substantial resurgence in global robot installations is anticipated in 2021, with a projected surge of 13% to 435,000 units. Thus, the upswing in industrial automation propels the expansion of the smart life sciences manufacturing market.

The escalating demand for personalized medicine is poised to be a driving force in the growth of the smart life sciences manufacturing market. Personalized medicine entails an approach to medical treatment and healthcare that customizes medical decisions, practices, interventions, and therapies to cater to individual patients. The mounting need for personalized medicine is compelling the life sciences sector to adopt smart manufacturing technologies and procedures, enabling efficient, precise, and adaptable production of customized pharmaceuticals and therapies, thus enhancing treatment outcomes. For instance, as of October 2022, reports from STAT, a US-based health-focused news organization, indicated a presence of over 75,000 genetic testing products and 300 personalized medicines. Additionally, in 2023, as per data from the Personalized Medicine Coalition, a US-based advocacy group, in 2022, the FDA granted approval for personalized medicines for 34% of new drugs, marking a consistent trend over the past eight years, where they were approved for at least 25% of new drugs. Therefore, the surge in demand for personalized medicine propels the expansion of the smart life sciences manufacturing market.

The rising concerns about data loss and data privacy are anticipated to pose a restraint on the smart life sciences manufacturing market in the foreseeable future. Data loss can have a substantial impact on the smart life sciences manufacturing (LSM) sector, which relies on cutting-edge technologies like the Internet of Things (IoT), data analytics, and automation to improve the efficiency and quality of pharmaceutical and biotechnology manufacturing processes. For instance, a recent analysis by Code42 Software in July 2023 revealed an uptick in insider data loss incidents within 70% of health sciences companies. These incidents pose significant risks to the industry, potentially leading to the compromise of private patient information, intellectual property, and sensitive research data. Hence, the mounting concerns over data loss and data privacy are acting as a constraint on the smart life sciences manufacturing market.

Major players in the market are directing their efforts towards the development of cutting-edge AI (artificial intelligence) medical technologies to maintain their market position. In the realm of smart life sciences, advancements in AI are crucial for the analysis and interpretation of extensive data sets, process optimization, and enabling more personalized engagements. For instance, in May 2023, Google Cloud Platform LLC, a US-based technology company, introduced two new AI-powered solutions aimed at expediting drug discovery and precision medicine. This groundbreaking tool holds the potential to significantly enhance the speed and efficiency of drug research. Moreover, it promises to enhance the accuracy of drug development and reduce the costs associated with bringing new drugs to market. Ultimately, this innovation has the capacity to accelerate the introduction of new drugs, ultimately benefiting patients' lives.

In October 2022, Burke Porter Group (BPG), a US-based company specializing in advanced technology solutions, completed the acquisition of D&K Engineering Inc. The specific financial terms of the deal remain undisclosed. Through this strategic move, Burke Porter Group seeks to augment its proficiency in life sciences, reinforce its manufacturing capabilities, and tap into D&K's valuable engineering know-how. D&K Engineering Inc. is a US-headquartered firm known for providing services in the realm of intelligent life sciences manufacturing.

Major players in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric Co., F. Hoffmann-La Roche AG, International Business Machines Corporation, AbbVie Inc., Merck and Co. Inc., Novartis AG, Sophos Group PLC, Bristol Myers Squibb, Thermo Fisher Scientific Inc., GlaxoSmithKline PLC, Sanofi S.A., AstraZeneca PLC, Honeywell International Inc., ABB Ltd., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Emerson Electric Co., Moderna Inc., Regeneron Pharmaceuticals, Biogen Inc., Vertex Pharmaceuticals, Rockwell Automation Inc., Bosch Rexroth AG, Alexion Pharmaceuticals, Fortinet Inc., Genentech Inc.

North America was the largest region in the smart life sciences manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smart life sciences manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart life sciences manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart life sciences manufacturing includes revenues earned by entities by providing services such as process automation and integration, supply chain optimization, bioprocessing solutions, process optimization, digital twin implementation and robotics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart life sciences manufacturing market also includes sales of manufacturing execution systems, robotic systems, laboratory automation equipment, real-time monitoring devices and Internet of Things (IoT) devices that are used in providing smart life sciences manufacturing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Smart Life Sciences Manufacturing Market Characteristics

3. Smart Life Sciences Manufacturing Market Trends And Strategies

4. Smart Life Sciences Manufacturing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Life Sciences Manufacturing Market Size and Growth

  • 5.1. Global Smart Life Sciences Manufacturing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Life Sciences Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Life Sciences Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Life Sciences Manufacturing Market Segmentation

  • 6.1. Global Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solutions
  • Services
  • 6.2. Global Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Augmented Reality And Virtual Reality Systems
  • Internet Of Things (IoT)
  • Artificial Intelligence
  • Cybersecurity
  • Big Data
  • Other Technologies
  • 6.3. Global Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharma
  • Bio-Pharma
  • Medical Device

7. Smart Life Sciences Manufacturing Market Regional And Country Analysis

  • 7.1. Global Smart Life Sciences Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Life Sciences Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Life Sciences Manufacturing Market

  • 8.1. Asia-Pacific Smart Life Sciences Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Life Sciences Manufacturing Market

  • 9.1. China Smart Life Sciences Manufacturing Market Overview
  • 9.2. China Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Life Sciences Manufacturing Market

  • 10.1. India Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Life Sciences Manufacturing Market

  • 11.1. Japan Smart Life Sciences Manufacturing Market Overview
  • 11.2. Japan Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Life Sciences Manufacturing Market

  • 12.1. Australia Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Life Sciences Manufacturing Market

  • 13.1. Indonesia Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Life Sciences Manufacturing Market

  • 14.1. South Korea Smart Life Sciences Manufacturing Market Overview
  • 14.2. South Korea Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Life Sciences Manufacturing Market

  • 15.1. Western Europe Smart Life Sciences Manufacturing Market Overview
  • 15.2. Western Europe Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Life Sciences Manufacturing Market

  • 16.1. UK Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Life Sciences Manufacturing Market

  • 17.1. Germany Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Life Sciences Manufacturing Market

  • 18.1. France Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Life Sciences Manufacturing Market

  • 19.1. Italy Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Life Sciences Manufacturing Market

  • 20.1. Spain Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Life Sciences Manufacturing Market

  • 21.1. Eastern Europe Smart Life Sciences Manufacturing Market Overview
  • 21.2. Eastern Europe Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Life Sciences Manufacturing Market

  • 22.1. Russia Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Life Sciences Manufacturing Market

  • 23.1. North America Smart Life Sciences Manufacturing Market Overview
  • 23.2. North America Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Life Sciences Manufacturing Market

  • 24.1. USA Smart Life Sciences Manufacturing Market Overview
  • 24.2. USA Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Life Sciences Manufacturing Market

  • 25.1. Canada Smart Life Sciences Manufacturing Market Overview
  • 25.2. Canada Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Life Sciences Manufacturing Market

  • 26.1. South America Smart Life Sciences Manufacturing Market Overview
  • 26.2. South America Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Life Sciences Manufacturing Market

  • 27.1. Brazil Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Life Sciences Manufacturing Market

  • 28.1. Middle East Smart Life Sciences Manufacturing Market Overview
  • 28.2. Middle East Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Life Sciences Manufacturing Market

  • 29.1. Africa Smart Life Sciences Manufacturing Market Overview
  • 29.2. Africa Smart Life Sciences Manufacturing Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Life Sciences Manufacturing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Life Sciences Manufacturing Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Life Sciences Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Smart Life Sciences Manufacturing Market Competitive Landscape
  • 30.2. Smart Life Sciences Manufacturing Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. General Electric Co.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Life Sciences Manufacturing Market Other Major And Innovative Companies

  • 31.1. International Business Machines Corporation
  • 31.2. AbbVie Inc.
  • 31.3. Merck and Co. Inc.
  • 31.4. Novartis AG
  • 31.5. Sophos Group plc
  • 31.6. Bristol Myers Squibb
  • 31.7. Thermo Fisher Scientific Inc.
  • 31.8. GlaxoSmithKline plc
  • 31.9. Sanofi S.A.
  • 31.10. AstraZeneca plc
  • 31.11. Honeywell International Inc.
  • 31.12. ABB Ltd.
  • 31.13. Eli Lilly and Company
  • 31.14. Gilead Sciences Inc.
  • 31.15. Amgen Inc.

32. Global Smart Life Sciences Manufacturing Market Competitive Benchmarking

33. Global Smart Life Sciences Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Life Sciences Manufacturing Market

35. Smart Life Sciences Manufacturing Market Future Outlook and Potential Analysis

  • 35.1 Smart Life Sciences Manufacturing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Life Sciences Manufacturing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Life Sciences Manufacturing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer